day 1 agenda
| Scientific Program | ||
| Day -1: June (29, 2026) | ||
| Meeting Hall - 1 | ||
| Registrations Open (08:30-09:10) | ||
| Opening Ceremony (09:10-09:30) | ||
| Moderator: Ana C Candia Solari Neumann, The University of Texas School of Dentistry, United States |
||
| Keynote Talks | ||
| Yifan Li, Shanxi Cancer Hospital, China |
09:30-10:00 | Title: How can precision medicine strategies be integrated into postoperative management for hepatobiliary, pancreatic, and gastric cancers? |
| Jagadananda Ghosh, Henry Ford Health System, United States |
10:00-10:30 | Title: Tribbles 2: A novel molecular target to overcome drug resistance in prostate cancer |
| Natalia Neparidze, Yale University, United States |
10:30-11:00 | Title: Systematic Community Outreach Efforts to Raise Awareness of Myeloma |
| Group Photo & Refreshment Break (11:00-11:20) | ||
| Scientific Session I | ||
| Session Chairs: Yifan Li, Shanxi Cancer Hospital, China & Jagadananda Ghosh, Henry Ford Health System, United States |
||
| Ana C Candia Solari Neumann, The University of Texas School of Dentistry, United States |
11:20-11:40 | Title: Tobacco Use and Eligibility for Lung Cancer Screening Among Dental Patients at an Academic Institution in Houston, Texas |
| Vimolmas Tansathitaya, College of Sports Science and Technology, Mahidol University, Thailand |
11:40-12:00 | Title: The Impact of Air Pollution on Lung Cancer Deformation: A Look at Nitrogen Dioxide Exposure and Long-Term Outdoor Physical Activity |
| Zhenqiang Yao, University of Rochester Medical Center, United States |
12:00-12:20 | Title: Localized apoptosis induction as a new strategy in solid cancer treatment |
| Melinda Ildiko Mitranovici, George Emil Palade University of Medicine, Romania |
12:20-12:40 | Title: Autophagy and its Dual Role, Similitudes and Differences between Trophoblast Cells and Cancer Stem Cells, a Narrative Review |
| Aisha Swaih, AstraZeneca, United Kingdom |
12:40-13:00 | Title: Development of best-in-class highly selective and blood-brain barrier penetrant irreversible TKI targeting EGFRExon20 Insertions |
| (13:00-14:00) Lunch Break @ Restaurant | ||
| Scientific Session II | ||
| SessionChairs: Thorsten Schaefer, University and University Hospital Basel, Switzerland & James William Tallon, The Christie NHS Foundation Trust, United Kingdom |
||
| Thorsten Schaefer, University and University Hospital Basel, Switzerland |
14:00-14:20 | Title: New insights into the functional significance of stem cell factor and oncogene SOX2 |
| Evangelia Florou, Kings College Hospital, United Kingdom |
14:20-14:40 | Title: Exceptional responders in advanced pancreatic cancer: rethinking resectability and tumour biology |
| Ben Chi-Bun Ko, The Hong Kong Polytechnic University, Hong Kong |
14:40-15:00 | Title: HER3 extracellular domain mutations sensitize HER2low breast cancer to Lapatinib and Trastuzumab treatment |
| Filippo Dell’Anno, Istituto Zooprofilattico sperimentale Piemonte, Liguria e Valle d'Aosta, Italy |
15:00-15:20 | Title: Environmental Pollution as a Driver of Cancer in Pets: Insights from Canine and Feline Epidemiology |
| James William Tallon, The Christie NHS Foundation Trust, United Kingdom |
15:20-15:40 | Title: MR guided uncertainty quantification of tumour motion in open face masks versus closed face masks in head and neck radiotherapy |
| Junfang Zheng, Capital Medical University, China |
15:40-16:00 | Title: KAT8-mediated MDH2 lactylation promotes renal cancer progression by enhancing mitochondrial function and stress resistance |
| Refreshment Break(16:00-16:10) | ||
| Haihe Wang, Sun Yat-sen University, China |
16:10-16:30 | Title: Roles of a small adaptor SH3BGRL in metastasis and chemo-resistance of breast tumor cells |
| Wan-Sheng Liu, The Pennsylvania State University, United States |
16:30-16:50 | Title: Shared RAR Pathway Mechanisms of PRAME Cancer/Testis Antigens in Germ Cells and Tumors |
| Arnon Blum, Ariel University, Israel |
16:50-17:10 | Title: RV size may predict death in unstable patients with PE |
| Pannel Discussions | ||
| Conference Hotel: Hotel Belstay Roma Aurelia Address: Via Bogliasco, 27, 00165 Roma RM, Italy |
||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||
day 2 agenda
| Scientific Program | ||
| Day -2: June (30, 2026) | ||
| Meeting Hall - 1 | ||
| Moderator: Sanya Arora, The London Clinic, United Kingdom |
||
| Keynote Talks | ||
| Ernest Kaninjing, Georgia College and State University, United States |
09:30-10:00 | Title: The Development of a Model of Acculturation and Health Practices Among Sub-Saharan African Men (MAPS) in the United States: a grounded theory study of prostate cancer early detection |
| Sinisa Dovat, Penn State University College of Medicine, United States |
10:00-10:30 | Title: Epigenomic regulation of tumor suppression in high-risk pediatric leukemia |
| Refreshment Break (10:30-10:40) | ||
| Scientific Session III | ||
| Session Chairs: Ernest Kaninjing, Georgia College and State University, United States & Sinisa Dovat, Penn State University College of Medicine, United States |
||
| Oluwaseun O. Akinduro, Mayo Clinic Florida, United States |
10:40-11:00 | Title: Inhibition of Yes-Associated Protein (YAP) with Verteporfin Enhances Radiosensitivity in Chordoma by Inhibiting the DNA Damage Response Cascade |
| Thukirtha Chelliah, Copenhagen University Hospital, Denmark |
11:00-11:20 | Title: Symptom burden and quality of life in patients with pancreatic and peri-pancreatic cancer at admission to specialized palliative care: a nationwide register-based study in Denmark |
| Sanya Arora, The London Clinic, United kingdom |
11:20-11:40 | Title: Risk-Adapted Real-World Implementation of Tarlatamab Enables Monitoring De-Intensification in Thoracic Oncology Practice |
| Abdulaziz Aloliqi, Qassim University, Saudi Arabia |
11:40-12:00 | Title: Identification and deciphering novel compounds dynamics against DTYMK |
| Gulcin Ertas, SBÜ Ankara Oncology Training and Researche Hospital, Turkey |
12:00-12:20 | Title: General features of metaplastic breast carcinoma and case of bilateral squamous cell MBC |
| Alessandra Storm Mauricio, Christian Brothers High School, United States |
12:20-12:40 | Title: Cancer awareness in teens: a hybrid cross-sectional survey and informational campaign |
| Hiba El Hajj, American University of Beirut, Lebanon |
12:40-13:00 | Title: Targeting Nucleophosmin-1 driven pathways: a novel therapeutic avenue for metastatic breast cancer |
| (13:00-14:00) Lunch Break @ Restaurant | ||
| Poster presentations (14:00-14:40) | ||
| Scientific Session IV | ||
| Session Chairs: Gulcin Ertas, SBÜ Ankara Oncology Training and Researche Hospital, Turkey & Hiba El Hajj, American University of Beirut, Lebanon |
||
| Maya Abdel Khalek, American University of Beirut, Lebanon |
14:40-15:00 | Title: NPM1: a potential therapeutic target in metastatic colorectal cancer |
| Jose Roberto Prieto Correa, University of Guadalajara, Mexico |
15:00-15:20 | Title: Expression of the receptor of advanced glycation end products (RAGE) and its effect on glucose metabolism in oral squamous cell carcinoma (OSSC) |
| Michal Bator, Lower Silesia Centre for Oncology, Pulmonology and Hematology in Wroclaw, Poland |
15:20-15:40 | Title: New Therapies in Multiple Myeloma: Benefits and Limitations |
| Yi Li, The Affiliated Hospital of Zunyi Medical University, China |
15:40-16:00 | Title: Influence of Frailty on Anesthesia Recovery Time in Elderly Patients Undergoing Curative Colorectal Cancer Resection: A Prospective Study |
| Refreshment Break(16:00-16:10) | ||
| Sirish Karri, Ariel University, Israel |
16:10-16:30 | Title: Fractal dimension–based image analysis reveals therapy-induced structural complexity and phenotypic heterogeneity in cancer cells |
| Chaochao Qin, Guangyuan Traditional Chinese Medicine Hospital, China |
16:30-16:50 | Title: The Multifaceted Roles of Chemokines in the Chronic Pancreatitis-to-Pancreatic Cancer Cascade: Implications for Pathogenesis and Precision Therapy |
| Iwona Inkielewicz-Stepniak, Medical University of Gdansk, Poland |
16:50-17:10 | Title: Therapeutic potential of selected natural compounds in enhancing the efficacy of opioid growth factor in pancreatic ductal adenocarcinoma treatment |
| Poster presentations (14:00-14:40) | ||
| Anke Wu, Chinese Academy of Medical Sciences and Peking Union Medical College, China |
WCCRT-I | Title: Lactate metabolism-driven tumor heterogeneity and molecular signatures in intrahepatic cholangiocarcinoma |
| Glykeria Georgia Rigana University of East Anglia, United kingdom |
WCCRT-II | Title: Synergistic Antitumour Activity of Carfilzomib and Benzyl Isothiocyanate Through Oxidative Stress–Mediated Cytotoxicity in TNBC |
| Maira Seiilgazy & Ayaulym Ibragimova, Nazarbaev University, Kazakhstan |
WCCRT-III | Title: Anticancer activity of artemisia vulgaris and its nanoparticle formulation against glioblastoma |
| Pannel Discussions | ||
| Closing Ceremony | ||
| Conference Hotel: Hotel Belstay Roma Aurelia Address: Via Bogliasco, 27, 00165 Roma RM, Italy |
||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||
Virtual Agenda
| Virtual Scientific Program | ||
| Day -2: June (30, 2026) | ||
| Virtual Presentations (Time Zone: CEST) | ||
| Farhana Sultana, Telstra Health, Australia |
10:00-10:20 | Title: Uptake and performance of self-collection offered through primary care to all eligible participants in a national cervical screening programme in Australia: a retrospective cohort study |
| Conor Kearney, Olivia Newton-John Cancer Research Institute, Australia |
10:20-10:40 | Title: Targeting TAK1 Overcomes Tumour-Intrinsic Resistance to T cell-mediated killing |
| Fangzhou Liu, Jiangsu Cancer Hospital, China |
10:40-11:00 | Title: COX5A promotes cell progression and cisplatin-resistance by alleviating mitochondrial dysfunction in head and neck squamous cell carcinoma |
| Speaker Slot Available | 11:00-11:20 | Speaker Slot Available |
| Changying Guo, Jiangxi Cancer Hospital, China |
11:20-11:30 | Title: Post-marketing safety evaluation of lurbinectedin: a pharmacovigilance analysis based on the FAERS database |
| Nuray Alaca, Acibadem University, Turkey |
11:30-11:40 | Title: The effect of manual lymph drainage on breast edema occurring after breast-conserving surgery and radiotherapy in breast cancer patients: a preliminary randomized controlled study |
| Neha Singh, All India Institute of Medical Sciences, Gorakhpur, India |
11:40-12:00 | Title: Mathematical Pathological Approach as a Novel Tool for Prognosis in Breast Cancer |
| Deepa Bhartiya, Tzar Genomics India Private Limited, India |
12:00-12:20 | Title: Dysfunctional, tissue-resident VSELs initiate cancer and result in its progression and metastasis, independent of EMT |
| Hao Sun, University College London, United Kingdom |
12:20-12:40 | Title: Bridging radiology and pathology: domain generalized cross-modal learning for clinical |
| Wojciech Trybus, Jan Kochanowski University of Kielce, Poland |
12:40-13:00 | Title: Alizarin sensitizes cervical and prostate cancer cells to venetoclax |
| Shuai Tan, Capital Medical University, China |
13:00-13:20 | Title: From a 2026 perspective: Platelet count ≠ its immunomodulatory function |
| Maria Santacana Espasa, Institut de Recerca Biomèdica de Lleida, Spain |
13:20-13:40 | Title: EPM2 AIP1 immunohistochemistry as a surrogate of promoter methylation analysis in endometrial carcinoma |
| João Paulo Kawaoka Matushita Junior, AC Camargo Cancer Center, Brazil |
13:40-14:00 | Title: Percutaneous Biliopancreatic Dual-Duct Intervention in Altered Anatomy Using Digital Cholangioscopy |
| Ewa Trybus, Jan Kochanowski University of Kielce, Poland |
14:00-14:20 | Title: Repurposing fexofenadine as a selective anticancer agent: oxidative stress–driven apoptosis and suppression of pro-survival signaling in 2D and 3D cancer models |
| Eleftherios Christodoulis, The Christie NHS Foundation Trust, United Kingdom |
14:20-14:40 | Title: Maintaining oxaliplatin therapy after hypersensitivity reactions: real-world experience with a desensitisation protocol |
| Helen Pearson, Cardiff University, United Kingdom |
14:40-15:00 | Title: Investigating BCL3 as a therapeutic target to treat prostate cancer |
| Robabeh Rahimi, University of Maryland School of Medicine, United States |
15:00-15:20 | Title: Enhancing Proton Therapy for Superficial Tumors Using Patient-Specific Bolus and Multi-Leaf Collimator |
| Carin F Gonsalves, Thomas Jefferson University Hospital, United States |
15:20-15:40 | Title: PEERLESS randomized controlled trial: Subanalysis of pulmonary embolism patient characteristics and outcomes by type of catheter-directed thrombolysis |
| Veda N. Giri, Yale University, United States |
15:40-16:00 | Title: Patient-Centered Approaches in the Evolving World of Germline Testing for Prostate Cancer |
| Christina Dieli-Conwright, Harvard Medical School, United States |
16:00-16:20 | Title: Exercise as Medicine in Genitourinary Oncology: Reducing Health Disparities in Prostate Cancer Survivors |
| Carisa A. Lozoraitis, UMass Memorial Health, United States |
16:20-16:40 | Title: 2021 Return-to-Screening ACS quality improvement project: Increasing mammography screenings post-COVID at UMass Memorial Medical Center |
| Alissa Michelle Wong, The Chinese University of Hong Kong, Hong Kong |
16:40-17:00 | Title: Organoid-based pharmacogenomics reveal therapeutic vulnerabilities in hepatocellular carcinoma |
| Abass Alavi, University of Pennsylvania, United States |
17:00-17:20 | Title: Evolving role of PET imaging in assessing vascular and central nervous system complications of radiation therapy in head and neck cancer |
| Kalyani Narra, Texas Christian University, United States |
17:20-17:40 | Title: Prostate cancer-related genetic counseling in a safety-net healthcare setting |
| Hao Xie, Mayo Clinic, United States |
17:40-18:00 | Title: Translational significance of the genomic landscape in KRAS G12D–mutant colorectal and pancreatic cancers |
| Ritu Shah & Rhea Ajaykumar Morani, Carnegie Vanguard High School, University of Texas MD Anderson Cancer Center, United States |
18:00-18:20 | Title: Carnegie Vanguard High School, University of Texas MD Anderson Cancer Center |
| Closing Ceremony | ||
| Conference Hotel: Hotel Belstay Roma Aurelia Address: Via Bogliasco, 27, 00165 Roma RM, Italy |
||
| If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com | ||